Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-29T13:59:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T14:36:33.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T13:38:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T14:34:13.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page shows a 403 Forbidden error with a basic header and a Home button, replacing the expected study record content. This indicates restricted access to the page rather than substantive changes to the study data.
    Difference
    18%
    Check dated 2026-09-24T19:44:39.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The revision on the study record updated to v3.7.0, indicating a new version of the page without changing its clinical details.
    Difference
    0.0%
    Check dated 2026-09-17T22:43:37.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.